Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.54 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.54 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.45 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL901572 | 0.98 | EPHX1 (0.57) | EPHX1CARM1PRMT6EPHX2APP | |
| SCHEMBL22393075 | 0.98 | EPHX1 (0.57) | EPHX1CARM1PRMT6EPHX2APP | |
| SCHEMBL901540 | 0.98 | EPHX1 (0.57) | EPHX1CARM1PRMT6EPHX2APP | |
| SCHEMBL23845320 | 0.98 | EPHX1 (0.57) | EPHX1CARM1PRMT6EPHX2APP | |
| SCHEMBL872221 | 0.96 | CARM1 (0.54) | EPHX1CARM1PRMT6EPHX2APP | |
| Hydrogen Sulfide SCHEMBL15066150 | 0.94 | CARM1 (0.53) | EPHX1CARM1PRMT6EPHX2APP | |
| Water SCHEMBL15066370 | 0.94 | CARM1 (0.53) | EPHX1CARM1PRMT6EPHX2APP | |
| SCHEMBL10055002 | 0.91 | CARM1 (0.57) | EPHX1CARM1PRMT6SMN1; SMN2NPC1 | |
| SCHEMBL18434523 | 0.91 | CARM1 (0.57) | EPHX1CARM1PRMT6SMN1; SMN2NPC1 | |
| SCHEMBL10055063 | 0.91 | CARM1 (0.57) | EPHX1CARM1PRMT6SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20220363786-A1 | GROUP 5 METAL COMPLEXES FOR PRODUCING AMINE-FUNTIONALIZED POLYOLEFINS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-11-17 | — | — | US | disclosed |
| US-20220363786-A1 | GROUP 5 METAL COMPLEXES FOR PRODUCING AMINE-FUNTIONALIZED POLYOLEFINS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-11-17 | — | — | US | disclosed |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-06-15 | — | — | US | disclosed |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-06-15 | — | — | US | disclosed |
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-10 | — | — | US | disclosed |
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-10 | — | — | US | disclosed |
| EP-3508477-A1 | C5AR ANTAGONISTS | ChemoCentryx, Inc. (US) | 2019-07-10 | — | — | EP | disclosed |
| US-5153226-A | Administering as anticholesterol agents, for atherosclerosis | WARNER-LAMBERT COMPANY (US) | 1992-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | ADH5, PRMT5, MAOA | EPHX1 1809/4885CARM1 60/4885PRMT6 38/4885 |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | ADH5, PRMT5, MAOA | EPHX1 1809/4885CARM1 60/4885PRMT6 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.